Life sciences news
-
argenx enters into agreement to acquire priority review voucher
Wednesday November 30th 2022
Read more
-
Monkeys not Donkeys, QbD Group’s life science marketing and communication agency, strengthens its team
Monday November 28th 2022
Read more
-
Ghent start-up Protealis accelerates local soybean development
Friday November 25th 2022
Read more
-
VIB researchers identify a new way of supporting and sensitizing immunotherapy in cancer patients
Friday November 25th 2022
Read more
-
Oxurion further improves THR-149 patent position
Thursday November 24th 2022
Read more
-
Pathomation releases an updated version PMA.transfer to easily manipulate whole slide images in digital pathology and virtual microscopy
Tuesday November 22nd 2022
Read more
-
Nathalie Draux succeeds Philippe Draux as CEO of Quality Assistance
Tuesday November 22nd 2022
Read more
-
argenx announces U.S. FDA acceptance of biologics license application for subcutaneous efgartigimod in generalized myasthenia gravis with priority review
Tuesday November 22nd 2022
Read more
-
Become a flanders.bio member
Your news here?
-
Oxurion: Interim analysis for KALAHARI trial planned by year-end 2022 with full top-line data expected in second half of 2023
Monday November 21st 2022
Read more
-
BGV co-leads €10 million seed investment in neuroscience company FundaMental Pharma
Thursday November 17th 2022
Read more
-
Rejuvenate Biomed’s newly appointed Clinical Advisory Board endorses Clinical Phase 2b strategy in sarcopenia
Tuesday November 15th 2022
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
